Akt inhibitor VIII [Ligand Id: 5921] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL258844
There should be some charts here, you may need to enable JavaScript!
  • AKT serine/threonine kinase 1/Serine/threonine-protein kinase AKT in Human [ChEMBL: CHEMBL4282] [GtoPdb: 1479] [UniProtKB: P31749]
There should be some charts here, you may need to enable JavaScript!
  • AKT serine/threonine kinase 2/Serine/threonine-protein kinase AKT2 in Human [ChEMBL: CHEMBL2431] [GtoPdb: 1480] [UniProtKB: P31751]
There should be some charts here, you may need to enable JavaScript!
  • AKT serine/threonine kinase 3/Serine/threonine-protein kinase AKT3 in Human [ChEMBL: CHEMBL4816] [GtoPdb: 2286] [UniProtKB: Q9Y243]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
RuvB-like 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3259467] [UniProtKB: Q9Y265]
ChEMBL Inhibition of RUVBL1 (unknown origin) B 4.62 pIC50 24000 nM IC50 Bioorg Med Chem (2022) 62: 116726-116726 [PMID:35364523]
AKT serine/threonine kinase 1/Serine/threonine-protein kinase AKT in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4282] [GtoPdb: 1479] [UniProtKB: P31749]
ChEMBL Inhibition of Akt1 by cell-based IPKA assay B 6.52 pIC50 305 nM IC50 Bioorg Med Chem Lett (2008) 18: 49-53 [PMID:18054229]
ChEMBL Inhibition of Akt1 by cell-based assay B 6.7 pIC50 200 nM IC50 Bioorg Med Chem Lett (2008) 18: 3178-3182 [PMID:18479914]
ChEMBL Inhibition of Akt1 B 7.24 pIC50 58 nM IC50 Bioorg Med Chem Lett (2008) 18: 49-53 [PMID:18054229]
ChEMBL Inhibition of human recombinant Akt1 B 7.24 pIC50 58 nM IC50 Bioorg Med Chem Lett (2008) 18: 2211-2214 [PMID:18296048]
ChEMBL Inhibition of Akt1 B 7.24 pIC50 58 nM IC50 Bioorg Med Chem Lett (2008) 18: 3178-3182 [PMID:18479914]
ChEMBL Inhibition of Akt1 B 7.24 pIC50 58 nM IC50 J Med Chem (2010) 53: 1413-1437 [PMID:20166671]
ChEMBL Inhibitory concentration against Akt1 kinase B 7.24 pIC50 58 nM IC50 Bioorg Med Chem Lett (2005) 15: 905-909 [PMID:15686884]
ChEMBL Inhibition of Akt1 (unknown origin) B 7.24 pIC50 58 nM IC50 Eur J Med Chem (2016) 113: 214-227 [PMID:26945110]
ChEMBL Inhibitory concentration against human Protein kinase B, alpha B 7.24 pIC50 58 nM IC50 Bioorg Med Chem Lett (2005) 15: 761-764 [PMID:15664853]
GtoPdb - - 7.24 pIC50 58 nM IC50 Bioorg Med Chem Lett (2005) 15: 761-4 [PMID:15664853]
AKT serine/threonine kinase 2/Serine/threonine-protein kinase AKT2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2431] [GtoPdb: 1480] [UniProtKB: P31751]
ChEMBL Inhibitory concentration against Akt3 kinase B 5.66 pIC50 >2200 nM IC50 Bioorg Med Chem Lett (2005) 15: 905-909 [PMID:15686884]
ChEMBL Inhibition of Akt2 by cell-based IPKA assay B 5.68 pIC50 2100 nM IC50 Bioorg Med Chem Lett (2008) 18: 49-53 [PMID:18054229]
ChEMBL Inhibition of Akt2 by cell-based assay B 6.05 pIC50 900 nM IC50 Bioorg Med Chem Lett (2008) 18: 3178-3182 [PMID:18479914]
ChEMBL Inhibition of Akt2 B 6.68 pIC50 210 nM IC50 Bioorg Med Chem Lett (2008) 18: 3178-3182 [PMID:18479914]
ChEMBL Inhibition of Akt2 B 6.68 pIC50 210 nM IC50 J Med Chem (2010) 53: 1413-1437 [PMID:20166671]
ChEMBL Inhibition of human recombinant Akt2 B 6.68 pIC50 210 nM IC50 Bioorg Med Chem Lett (2008) 18: 2211-2214 [PMID:18296048]
ChEMBL Inhibitory concentration against human Protein kinase B, Akt2 B 6.68 pIC50 210 nM IC50 Bioorg Med Chem Lett (2005) 15: 761-764 [PMID:15664853]
ChEMBL Inhibition of Akt2 B 6.68 pIC50 210 nM IC50 Bioorg Med Chem Lett (2008) 18: 49-53 [PMID:18054229]
GtoPdb - - 6.68 pIC50 210 nM IC50 Bioorg Med Chem Lett (2005) 15: 761-4 [PMID:15664853]
ChEMBL Inhibition of Akt2 (unknown origin) B 8 pIC50 10 nM IC50 Eur J Med Chem (2016) 113: 214-227 [PMID:26945110]
AKT serine/threonine kinase 3/Serine/threonine-protein kinase AKT3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4816] [GtoPdb: 2286] [UniProtKB: Q9Y243]
ChEMBL Inhibition of Akt3 by cell-based IPKA assay B 5 pIC50 >=10000 nM IC50 Bioorg Med Chem Lett (2008) 18: 49-53 [PMID:18054229]
ChEMBL Inhibition of Akt3 B 5.66 pIC50 2200 nM IC50 Bioorg Med Chem Lett (2008) 18: 49-53 [PMID:18054229]
ChEMBL Inhibition of Akt3 (unknown origin) B 5.66 pIC50 2200 nM IC50 Eur J Med Chem (2016) 113: 214-227 [PMID:26945110]
GtoPdb - - 5.67 pIC50 2119 nM IC50 Bioorg Med Chem Lett (2005) 15: 761-4 [PMID:15664853]
ChEMBL Inhibitory concentration against human Protein kinase B, Akt3 B 5.67 pIC50 2119 nM IC50 Bioorg Med Chem Lett (2005) 15: 761-764 [PMID:15664853]
ChEMBL Inhibition of human recombinant Akt3 B 5.67 pIC50 >2119 nM IC50 Bioorg Med Chem Lett (2008) 18: 2211-2214 [PMID:18296048]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]